Schedule 13G ownership disclosure

OUTLOOK THERAPEUTICS INC

Security class unavailable · CUSIP: 69012T206

Event date: 2019-05-15

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,316,732
Percent of class
5.9600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001535610-19-000086
Form type
SC 13G
Filer
Outlook Therapeutics, Inc.
CIK
CIK 1649989
Filed
May 22, 2019
Reporting period
May 15, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub